Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

LTPat-based SOXFE: A self-organized explainable feature engineering model for automated fibromyalgia detection.

Created on 10 Oct 2026

Authors

Yasemin Kirik, Serkan Kirik, Omer Faruk Goktas, Burak Tasci, Sengul Dogan, Turker Tuncer

Published in

Technology and health care : official journal of the European Society for Engineering and Medicine. Pages 9287329261495183. Oct 10, 2026. Epub Oct 10, 2026.

Abstract

BackgroundFibromyalgia is a chronic pain disorder associated with sleep disturbance and substantial functional burden.ObjectiveThis study evaluated a self-organized explainable feature engineering (SOXFE) model for EEG-based fibromyalgia classification.MethodsA previously reported sleep EEG dataset from a 32-participant source cohort was analyzed separately for NREM Stage 2 and Stage 3. The analysis-ready version contained 136 labeled stage-record files: 74 for Stage 2 and 62 for Stage 3. The SOXFE model comprised LTPat feature extraction, training-only CWNCA feature selection, tkNN classification, IMV information fusion, and DLob-based explanation. Record-wise LORO was primary; segment-level 10-fold cross-validation was complementary.ResultsRecord-wise LORO used 74 outer folds for Stage 2 and 62 for Stage 3. Descriptive pooled held-out-epoch accuracy was 92.77% (95% CI: 91.76-93.67) for Stage 2 and 97.00% (95% CI: 96.22-97.63) for Stage 3. Every epoch from the held-out recording was excluded from training and selection. Complementary segment-level 10-fold cross-validation yielded 100.00% accuracy for both stages but was not used as evidence of record-wise generalization.ConclusionsThe model provided record-disjoint classification and traceable model-derived explanations in this single-source dataset. LORO prevented within-record epoch leakage. However, participant linkage was unavailable, so records from the same person may have occurred across outer partitions and the reported values may overestimate person-independent performance. Verified subject-wise validation is required before clinical use.

PMID:
42856024
Bibliographic data and abstract were imported from PubMed on 10 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement